1Mignatti P.Extracellular matrix remodeling by metalloproteinases and plasminogen activators.Kiddy Int,1995,47(suppl):S12-14.
2Schnaper HW. Balance between matrix synthesis and degradation:a determinant of glomerulosclerosis. Pediatr Nephrol,1995,9(1):104-111.
3Bosma PJ, Eva A, Van den Berg, Kooistra T, et al. Human plasminogen activator inhibitor-1 gene.J Biol Chem, 1998,263(19):9129-9141.
4Bruzdzinski CJ, Johnson MR, Nordhy EC,et al.lsolation and characterization of the rat plasminogen activator inhibitor-1 gene.J Biol Chem,1990,265(4):2078-2085.
6Kutz SM, Nikey SAT, White LA, et al.Induced PAl-1 mRNA expression and targeted protein accumulation are early G1 events in serum-stimulated rat kidney cells, J Cell Physiol.1997,170:8-18.
7Colucci M.Gsualdo L,Montemurro P,et al.Cultured humanmesangial cells produce both type I and type 2 plasminogen activator inhibitors.Thromb Haemost, 1995,74((6):1516-1520.
8Lacava R,Rondeau E.Ochi S,et al.Characterization of a ptasminogen activator and its inhibitor in human mesangial cells. Kidney Int,1989,35,806-811.
9Hagege J, Peraldi MN, Rondeau E, et al. Plasminogen activator inhibitor-1 deposition in the extracellular matrix of cultured human mesangial cells.Am J Pathol,1992,141(1):117-128.
10Tomooka S, Border WA, Marshall BC, et al. Glomerular matrix accumulation is linked to inhibition of the plasmin protease system. Kidney Int,1992,42:1462-1469.
